Drug development worldwide is marked by increasingly complex molecular structures and physicochemical profiles, faster development cycles, and closer collaboration across regions. With challenges spanning drug candidate developability, process manufacturability, global regulatory submissions, and commercial supply, establishing a phase-appropriate CMC strategy early has become critical to reducing development risk, improving the likelihood of development success, and enhancing pipeline value.
On November 5–6, 2026, PharmaBlock will host the CMC Lifecycle Strategy Forum in Nanjing under the theme “Take the Smarter Path.” Bringing together industry experts with global experience in drug development and commercialization, the forum will focus on CMC development for small molecules, peptides, and antibody-drug conjugates (ADCs). Discussions will address early CMC integration, critical technical decisions, and collaboration across the drug development lifecycle. Drawing on PharmaBlock’s practical experience in green and intelligent chemistry, the forum will explore drug development approaches that balance development efficiency, process manufacturability, and sustainability.
Event Theme: CMC Lifecycle Strategy Forum: Take the Smarter Path
Hosted by: PharmaBlock
Organized by: BioValley
Dates:
November 5, 2026: Facility tours, starting at 2:00 p.m. (Registration closed)
November 6, 2026: Full-day Forum
Venue: Longshan Lake Hotel, Jiangbei New Area, Nanjing（7 Yaogu Avenue, Jiangbei New Area, Nanjing, China）
Expected Attendance: 60–80 participants
Who Should Attend
·Executives, heads of R&D, CMC, quality, regulatory affairs, and manufacturing, and project leaders from biotech and pharmaceutical companies developing innovative therapies, including small molecules, peptides, and ADCs.
·Experts and researchers from universities and research institutions.
·Suppliers, equipment providers, and technology service providers serving the pharmaceutical industry.
·Representatives from pharmaceutical investment firms and organizations supporting industry partnerships.
